G01N 2333/91028
Hydroxymethyl-, formyl-transferases
Official title: Hydroxymethyl-, formyl-transferases (2.1.2)
G01N2333/91028 (Hydroxymethyl-, formyl-transferases) appears on 3 US grants and 6 published applications in this corpus.
Search patents in G01N- Granted patents
- 3
- Published applications
- 6
- Assignees
- 3
- Inventors
- 11
- Latest grant
- 15 Nov 2016
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 1 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 1 | 1 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 1 | 1 |
By publication year.
Recent patents
- Inhibition of the glycine cleavage system for treatment of cancer15 Nov 2016US 9,493,775 B2Whitehead Institute for Biomedical Research
- Protein markers for the diagnosis and prognosis of ovarian and breast cancer29 May 2012US 8,187,889 B2Ludwig Institute for Cancer Research
- Methods and compositions for modulating cell proliferation7 Aug 2007US 7,252,944 B2Irm LLC
- Peptidomimetic compounds and related methods8 Dec 2016US 2016/0357901 A1
- Inhibition of the glycine cleavage system for treatment of cancer8 Jan 2015US 2015/0011611 A1Whitehead Institute for Biomedical Research
- Peptidomimetic compounds and related methods31 Oct 2013US 2013/0288331 A1
- Protein markers for the diagnosis and prognosis of ovarian and breast cancer20 Sep 2012US 2012/0238478 A1
- Protein markers for the diagnosis and prognosis of ovarian and breast cancer4 Sep 2008US 2008/0213907 A1Ludwig Institute for Cancer Research
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.